We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Rocket Lab Corp
RKLB
$35.3B
| $6.86M | 0.01% |
+191,774
| New | +$4.69M |
2025 Q2
0 quarters
|
|
652
Cinemark Holdings
CNK
$4.46B
| $6.84M | 0.01% |
226,668
-455,538
| -67% | -$13.8M |
2023 Q2
8 quarters
|
|
653
Otis Worldwide
OTIS
$26.8B
| $6.81M | 0.01% |
68,797
-53,626
| -44% | -$5.18M |
2020 Q2
20 quarters
|
|
654
Dover
DOV
$26.1B
| $6.76M | 0.01% |
36,901
-6
| -0% | -$1.04K |
2013 Q2
48 quarters
|
|
655
QCR Holdings
QCRH
$1.62B
| $6.71M | 0.01% |
98,828
| – | – |
2014 Q2
44 quarters
|
|
656
Dentsply Sirona
XRAY
$1.76B
| $6.69M | 0.01% |
421,556
+186,952
| +80% | +$2.8M |
2013 Q2
48 quarters
|
|
657
MaxLinear
MXL
$7.09B
| $6.68M | 0.01% |
469,807
+332,932
| +243% | +$3.84M |
2025 Q1
1 quarter
|
|
658
Fluence Energy
FLNC
$921M
| $6.67M | 0.01% |
994,064
+452,896
| +84% | +$2.16M |
2023 Q1
9 quarters
|
|
659
Kestra Medical Technologies
KMTS
$1.71B
| $6.63M | 0.01% |
400,000
| – | – |
2025 Q1
1 quarter
|
|
660
Kirby Corp
KEX
$7.24B
| $6.53M | 0.01% |
57,617
-5,519
| -9% | -$579K |
2013 Q2
48 quarters
|
|
661
CME Group
CME
$104B
| $6.5M | 0.01% |
23,572
+21,918
| +1,325% | +$5.96M |
2013 Q2
48 quarters
|
|
662
Accenture
ACN
$138B
| $6.42M | 0.01% |
21,464
-12,564
| -37% | -$3.83M |
2013 Q2
48 quarters
|
|
663
ZoomInfo Technologies
GTM
$1.19B
| $6.39M | 0.01% |
631,570
-383,557
| -38% | -$3.55M |
2020 Q2
20 quarters
|
|
664
Teleflex
TFX
$5.43B
| $6.37M | 0.01% |
53,781
+1,353
| +3% | +$171K |
2013 Q2
48 quarters
|
|
665
DELISTED
ON24
ONTF
| $6.37M | 0.01% |
1,172,241
+4,578
| +0.4% | +$23.5K |
2022 Q1
13 quarters
|
|
666
Tanger
SKT
$4.06B
| $6.35M | 0.01% |
207,627
+12,365
| +6% | +$379K |
2023 Q3
7 quarters
|
|
667
Circle Internet Group
CRCL
$22.1B
| $6.35M | 0.01% |
+35,000
| New | +$5.7M |
2025 Q2
0 quarters
|
|
668
HCI Group
HCI
$2.44B
| $6.3M | 0.01% |
41,368
-71
| -0.2% | -$10.9K |
2023 Q4
6 quarters
|
|
669
Mitsubishi UFJ Financial
MUFG
$246B
| $6.22M | 0.01% |
453,416
-173,667
| -28% | -$2.25M |
2021 Q2
16 quarters
|
|
670
4D Molecular Therapeutics
FDMT
$711M
| $6.19M | 0.01% |
1,667,338
+417,157
| +33% | +$1.47M |
2024 Q4
2 quarters
|
|
671
Pinnacle Financial Partners Inc
PNFP
$14.3B
| $6.18M | 0.01% |
55,976
-71
| -0.1% | -$7.33K |
2017 Q2
32 quarters
|
|
672
Western Union
WU
$1.94B
| $6.17M | 0.01% |
732,676
+314,030
| +75% | +$2.98M |
2013 Q2
48 quarters
|
|
673
SunCoke Energy
SXC
$864M
| $6.16M | 0.01% |
716,633
-120,942
| -14% | -$1.05M |
2020 Q1
21 quarters
|
|
674
BrightView Holdings
BV
$975M
| $6.15M | 0.01% |
369,413
+3,044
| +0.8% | +$45.5K |
2023 Q2
8 quarters
|
|
675
Capri Holdings
CPRI
$1.8B
| $6.15M | 0.01% |
347,206
+325,241
| +1,481% | +$5.36M |
2020 Q1
21 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.